3 Hrs
Source:
الوطن
Pharma Bolsters Security
The Sultanate of Oman is seeking to strengthen health and pharmaceutical security and reduce reliance on imports by developing its pharmaceutical industry. This includes three projects in the Wilayat of Sohar, in North Al Batinah Governorate: Al-Wajer Pharmaceuticals, Drug Manufacturing Company (DMC), and Penicillin Integrated Industries Company (Pen-G). Together, they span stages of production ranging from pharmaceutical granules to raw materials and the active ingredients used in antibiotics. These projects support local manufacturing, non-oil exports, and economic diversification in line with Oman Vision 2040. Since beginning operations in 2018, Al-Wajer has developed more than 18 specialized products and exports all of its output to markets in Asia, Africa, Latin America, and the Middle East. The article underscores the importance of continued investment in scientific research and technology, expanding partnerships with universities, research centers, and health authorities, and developing national talent to ensure the sector’s growth and competitiveness.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)